Orum Therapeutics Inc. logo

Orum Therapeutics Inc. (475830)

Market Open
11 Aug, 06:30
KRX SM KRX SM
70,800. 00
+900
+1.2876%
1.33T Market Cap
- P/E Ratio
- Div Yield
47,748 Volume
- Eps
69,900
Previous Close
Add Transaction
Day Range
68,000 74,000
Year Range
22,050 146,600
Want to track 475830 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Orum Therapeutics Inc. (475830) Statistics

Valuation metrics

Market Cap 1.33T
Enterprise value 1.23T
Trailing P/E (ttm) -91.28
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 89,439,658.22
Price/Book (mrq) 11.68
Enterprise Value/Revenue 83,553,886.6
Enterprise Value/EBITDA -71.08

Overview

Shares outstanding 21.16M
Float 15.27M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.02%
Average volume (10 days) 136.33K
Average volume (90 days) 185.51K

Price summary

52-Week low 22,050
52-Week high 146,600
Beta -
50-Day moving average 50,480
200-Day moving average 83,745.93

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -1,041,294.39%
Operating margin -1,232,013.58%

Operational effectiveness

Return on assets -0.05%
Return on equity -0.22%

Income Statement

Revenue (ttm) 23.56M
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -0.78%
Gross profit (ttm) 23.31M
EBITDA -48.46B
Net income to common (ttm) -41.97B
Diluted EPS (ttm) -678.04
Quarterly earnings growth (yoy) -0.77%

Balance Sheet

Total cash (mrq) 132.6B
Total cash per share (mrq) 12,151.68
Total debt (mrq) 25.5B
Total Debt/Equity (mrq) 0.22
Current ratio (mrq) 1.63%
Book value per share (mrq) 5,298.5

Cash Flow

Cash flow statement -35.99B
Levered free cash flow (LFCF) -19.89B